Tokyo Tape
Sign in
← Jmdc

Quarterly report · Q1

4483.TEDINET S100RPCP
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥6.7bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥27.8bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥5.8bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥2.5bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥1.1bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax¥2.6bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥5.9bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥2.0bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥765m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥2.0bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥759m2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥97.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥98.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥63.3bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥31.7bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥34.0bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥65.8bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥64.5bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥31.4bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥31.2bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥65.9bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥64.5bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥31.4bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥23.0bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥22.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥4.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥22.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥3.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥273m2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥28.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥909m2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥32.422023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.172022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥13.552022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥31.072023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.692022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥12.732022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio67.5%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio65.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio49.7%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥76m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥76m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥151m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2023-04-01 → 2023-06-30¥969m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2023-04-01 → 2023-06-30¥919m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥50m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2023-04-01 → 2023-06-30¥87m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2023-04-01 → 2023-06-30¥4.5bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2023-04-01 → 2023-06-30¥4.5bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥25m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥448m
—segment totalrevenue2023-04-01 → 2023-06-30¥6.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥6.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥76m
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.8bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥90m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥910m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥869m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥41m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥47m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2022-04-01 → 2022-06-30¥1.1bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥439m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥58m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 632
ItemContextValueUnit
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Equity IFRSPrior2YearInstant_ShareAcquisitionRightsIFRSMember21000000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-1000000JPY
Other comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember4000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-1000000JPY
Comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember4000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Exercise of share acquisition rights ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember21000000JPY
Exercise of share acquisition rights ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember21000000JPY
Exercise of share acquisition rights ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Exercise of share acquisition rights ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Exercise of share acquisition rights ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Exercise of share acquisition rights ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember-0JPY
Dividends ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Increase decrease by business combination ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Increase decrease by business combination ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Increase decrease by business combination ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Increase decrease by business combination ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Increase decrease by business combination ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Increase decrease by business combination ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Transfer to retained earnings ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Transfer to retained earnings ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Transfer to retained earnings ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Transfer to retained earnings ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Transfer to retained earnings ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4000000JPY
Transfer to retained earnings ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareCapitalIFRSMember21000000JPY
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember21000000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4000000JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember-0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass